These findings have illuminated a novel function of Ninj1 in bone homeostasis, suggesting that Ninj1 is one of the several molecular regulators of osteoclast development and thus represents a potential therapeutic target in human destructive bone disorders. The gene discussed is NINJ1; the disease is bone disorder.